Rising Regulatory Hurdles And Market Saturation Will Bar Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 35 Analysts
Published
09 Apr 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
US$97.27
25.0% overvalued intrinsic discount09 Aug
US$121.61
1Y
4.6%7D
-6.8%